Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

Short-acting insulin covers the spike in glucose that comes with meals. Long-acting insulin lasting around 24 hours manages the time between meals and at night. Covering three meals and the rest ...

Until the advent of lente insulin the preparation of insulins ... In the preparation of these long-acting insulins a phosphate buffer has commonly been used. Under these conditions, the use ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

By contrast, the binding of a long-acting human insulin to its receptor was not altered by glucose concentration. Diabetes prevention programme put to the test When insulin binds to its receptor ...

“The combination of these two features should allow for more aggressive insulin titration without increasing the risk of hypoglycemia. This could improve both the short-term and long-term risks ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

23 letters to CEOs of the three pharmaceutical giants, the lawmakers said insulin was a "critical public health need" and ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

November is National Diabetes month, and it’s a great time to raise awareness about diabetes and to learn how to prevent or delay Type 2 diabetes, especially if it runs in your family. Well, let me ...

23 letters to CEOs of the three pharmaceutical giants, the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need short-acting ...